Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
25.23
-0.44 (-1.71%)
At close: Oct 6, 2026, 4:00 PM EDT
25.23
0.00 (0.00%)
Pre-market: Oct 7, 2026, 5:48 AM EDT
Beam Therapeutics Market Cap
Beam Therapeutics has a market cap or net worth of $2.52 billion as of October 6, 2026. Its market cap has decreased by -0.38% in one year.
Market Cap
2.52B
Enterprise Value
1.62B
1-Year Change
-0.38%
Ranking
Category
Stock Price
$25.23
ChartMarket Cap Chart
Since February 6, 2020, Beam Therapeutics's market cap has increased from $327.97M to $2.52B, an increase of 668.70%. That is a compound annual growth rate of 35.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 2.52B | -7.85% |
| Dec 31, 2025 | 2.74B | 38.60% |
| Dec 31, 2024 | 1.97B | -8.58% |
| Dec 29, 2023 | 2.16B | -19.78% |
| Dec 30, 2022 | 2.69B | -49.47% |
| Dec 31, 2021 | 5.33B | 15.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 6, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zai Lab | 2.87B |
| MBX Biosciences | 2.74B |
| Precigen | 2.70B |
| NewAmsterdam Pharma Company | 2.66B |
| Recursion Pharmaceuticals | 2.48B |
| Celldex Therapeutics | 2.43B |
| Disc Medicine | 2.37B |
| Nurix Therapeutics | 2.35B |